Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Recruiting 1Active not recruiting 1

Sponsor Class

NETWORK 2NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2

Conditions

Rhabdomyosarcoma 5Uterine Cervical Neoplasms 4Prostatic Neoplasms 4Medulloblastoma 4Wilms Tumor 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Neuroblastoma 3Ganglioneuroblastoma 3Central Nervous System Neoplasms 3Burkitt Lymphoma 3Squamous Cell Carcinoma of Head and Neck 2Sarcoma 2Rhabdomyosarcoma, Embryonal 2Rectal Neoplasms 2Oropharyngeal Neoplasms 2Gliosarcoma 2Glioblastoma 2Endometrial Clear Cell Adenocarcinoma 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Astrocytoma 2Teratoma 1Stage I Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 1Spinal Cord Neoplasms 1Sarcoma, Ewing 1Rhabdomyosarcoma, Alveolar 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Neuroectodermal Tumors, Primitive, Peripheral 1Neoplasms 1

Interventions

Vincristine 2Radiotherapy 2Radiation 2Magnetic Resonance Spectroscopy 2Dactinomycin 2Cyclophosphamide 2Biopsy 2X-Rays 1Vinorelbine 1Specimen Handling 1Phantoms, Imaging 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Rhabdomyosarcoma, Embryonal × Radiation × Clear all
NCT04994132 2026-05-05

A Study to Compare Early Use of Vinorelbine and Maintenance Therapy for Patients With High Risk Rhabdomyosarcoma

Children's Oncology Group

Phase 3 Active not recruiting
118 enrolled
Sarcoma

Rhabdomyosarcoma, Rhabdomyosarcoma, Alveolar, Rhabdomyosarcoma, Embryonal

NCT05304585 2026-05-05

Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma

Children's Oncology Group

Phase 3 Recruiting
205 enrolled
Sarcoma

Rhabdomyosarcoma, Embryonal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡